These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9533068)

  • 61. [Carvedilol in cardiac decompensation].
    Dib J
    Rev Med Liege; 1996 Feb; 51(2):198-200. PubMed ID: 8650455
    [No Abstract]   [Full Text] [Related]  

  • 62. [Carvedilol therapy in pediatric patients with Takayasu's arteritis complicated with congestive heart failure: a case report].
    Wu XY; Song HM; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Apr; 47(4):315-6. PubMed ID: 19555579
    [No Abstract]   [Full Text] [Related]  

  • 63. Successful treatment of cocaine-induced cardiotoxicity with carvedilol therapy.
    Öcal L; Çakir H; Tellice M; İzci S; Alizade E; Esen AM
    Herz; 2015 Feb; 40(1):159-61. PubMed ID: 24173375
    [No Abstract]   [Full Text] [Related]  

  • 64. Pharmacogenetics and heart failure: a convergence with carvedilol.
    Meadowcroft AM; Williamson KM; Patterson JH; Pieper JA
    Pharmacotherapy; 1997; 17(4):637-9. PubMed ID: 9250542
    [No Abstract]   [Full Text] [Related]  

  • 65. [Therapy with beta blockers in heart failure. Recent studies of carvedilol].
    Böhm M; Erdmann E
    Fortschr Med; 1996 May; 114(13):167-8. PubMed ID: 8964561
    [No Abstract]   [Full Text] [Related]  

  • 66. Carvedilol [Coreg].
    Kukin M
    Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
    [No Abstract]   [Full Text] [Related]  

  • 67. Using carvedilol to treat heart failure.
    Taccetta-Chapnick M
    Crit Care Nurse; 2002 Apr; 22(2):36-40, 42-6, 48 passim. PubMed ID: 11961943
    [No Abstract]   [Full Text] [Related]  

  • 68. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 69. [Carvedilol (dilatrend) treatment in cardiac failure].
    Drapkina OM; klimenkov AV; Ivashkin VT
    Ter Arkh; 2004; 76(12):88-90. PubMed ID: 15724937
    [No Abstract]   [Full Text] [Related]  

  • 70. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
    Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
    Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Special considerations for carvedilol use in heart failure.
    Yancy CW
    Am J Cardiol; 2004 May; 93(9A):64B-8B. PubMed ID: 15144941
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of carvedilol in atrial fibrillation: insights from clinical trials.
    Gheorghiade M; Lukas MA
    Am J Cardiol; 2004 May; 93(9A):53B-7B. PubMed ID: 15144939
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Carvedilol use in heart failure.
    Neal CP; Kendrach MG
    Ann Pharmacother; 1998 Mar; 32(3):376-81. PubMed ID: 9533068
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.